High serum levels of sPD-L1 are related to poor prognosis in various cancers, such as hepatocellular carcinoma, esophageal cancer, lung cancer, gastric cancer, rectal cancer, and lymphoma [23]. This evidence concerns the gene SPDL1 and lung cancer.